Pliant Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.77 | -$0.77 | -$0.77 |
| Q2 2024 | 6 | -$0.85 | -$0.85 | -$0.85 |
| Q3 2024 | 3 | -$0.97 | -$0.97 | -$0.97 |
| Q4 2024 | 8 | -$1.06 | -$0.81 | -$0.99 |
| Q1 2025 | 5 | -$1.05 | -$0.89 | -$0.99 |
| Q2 2025 | 4 | -$1.02 | -$1.02 | -$1.02 |
| Q3 2025 | 4 | -$1.05 | -$1.05 | -$1.05 |
| Q4 2025 | 4 | -$1.08 | -$1.08 | -$1.08 |
| Q1 2026 | 3 | -$1.02 | -$1.02 | -$1.02 |
| Q2 2026 | 3 | -$1.02 | -$1.02 | -$1.02 |
| Q3 2026 | 3 | -$1.02 | -$1.02 | -$1.02 |
| Q4 2026 | 3 | -$0.99 | -$0.99 | -$0.99 |
Pliant Therapeutics, Inc. Earnings Date And Information
Pliant Therapeutics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.95 earnings per share for the quarter, topping analysts' consensus estimates of $-0.97 by $0.02. The company had revenue of 0 for the quarter and had revenue of 1.58 M for the year. Pliant Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-2.75 diluted earnings per share) and currently has a price-to-earnings ratio of -3.87. Pliant Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Pliant Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.97 | -$0.95 | 0.02 | $472,222 | $0 |
| 08/07/2024 | Q2 2024 | -$0.85 | -$0.92 | -0.07 | $732,500 | $0 |
| 05/06/2024 | Q1 2024 | -$0.76 | -$0.78 | -0.02 | $0 | |
| 02/27/2024 | Q4 2023 | -$0.81 | -$0.69 | 0.12 | $4.84 M | |
| 11/09/2023 | Q3 2023 | -$0.78 | -$0.70 | 0.08 | $1.02 M | $0 |
| 08/09/2023 | Q2 2023 | -$0.73 | -$0.70 | 0.03 | $1.21 M | $248,000 |
| 05/09/2023 | Q1 2023 | -$0.66 | -$0.50 | 0.16 | $1.33 M | |
| 03/09/2023 | Q4 2022 | -$0.70 | -$0.71 | -0.01 | $1.97 M | |
| 11/08/2022 | Q3 2022 | -$0.74 | -$0.60 | 0.14 | $1.79 M | $1.48 M |
| 08/08/2022 | Q2 2022 | -$0.82 | -$0.82 | 0 | $1.35 M | $4.99 M |
| 05/09/2022 | Q1 2022 | -$0.77 | -$0.77 | 0 | $1.25 M | |
| 02/28/2022 | Q4 2021 | -$0.68 | $2.00 M | |||
| 11/09/2021 | Q3 2021 | -$0.71 | -$0.75 | -0.04 | $3.17 M | $1.61 M |
| 08/09/2021 | Q2 2021 | -$0.64 | -$0.64 | 0 | $4.17 M | $1.79 M |
| 05/10/2021 | Q1 2021 | -$0.59 | -$0.64 | -0.05 | $2.17 M | |
| 03/16/2021 | Q4 2020 | -$0.71 | -$0.54 | 0.17 | $4.47 M | |
| 11/10/2020 | Q3 2020 | -$1.10 | -$0.47 | 0.63 | $2.50 M | $4.81 M |
| 08/11/2020 | Q2 2020 | -$0.77 | -$1.39 | -0.62 | $3.70 M | $3.60 M |
| 03/30/2020 | Q1 2020 | $0.51 | $28.94 M | |||
| 12/30/2019 | Q4 2019 | $1.93 | $57.05 M |
Pliant Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Pliant Therapeutics, Inc.'s earnings date?
Pliant Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
-
Did Pliant Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Pliant Therapeutics, Inc. (:PLRX) reported $-0.95 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.97 by $0.02.
-
How can I listen to Pliant Therapeutics, Inc.'s earnings conference call?
The conference call for Pliant Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Pliant Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Pliant Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Pliant Therapeutics, Inc. generate each year?
Pliant Therapeutics, Inc. (:PLRX) has a recorded annual revenue of $1.58 M.
-
How much profit does Pliant Therapeutics, Inc. generate each year?
Pliant Therapeutics, Inc. (:PLRX) has a recorded net income of $1.58 M. Pliant Therapeutics, Inc. has generated $-2.75 earnings per share over the last four quarters.
-
What is Pliant Therapeutics, Inc.'s price-to-earnings ratio?
Pliant Therapeutics, Inc. (:PLRX) has a price-to-earnings ratio of -3.87 and price/earnings-to-growth ratio is 0.48.
